Many studies inhibiting tumor proliferation by targeting CDK1 have obtained meaningful results—for instance, miR-181a inhibits cell proliferation by regulating the expression of CDK1 in NSCLC cells (71). This evidence concerns the gene CDK1 and non-small cell lung carcinoma.